baber/WOPTO huggingface dataset:
Patent JP-2698636-B2 (JP)
IPC: B63H/
Filed: 1988-05-20
Granted: 1998-01-19
Abstract: PCT No. PCT/SE88/00270 Sec. 371 Date Nov. 16, 1989 Sec. 102(e) Date Nov. 16, 1989 PCT Filed May 20, 1988 PCT Pub. No. WO88/09288 PCT Pub. Date Dec. 1, 1988.A reversing device of a jet propulsion assembly for ships. The jet propulsion assembly includes a steering means connected to the outlet of a pump, for steering the driving water jet, the steering means including two flaps for reversing the driving water jet. An actuator pivots a first flap downwards around a first bearing across the water jet, at the same time as link arms, which are journalled between the front edges of the first flap and second flap, swing the second flap around a second bearing. The rear portion of the second flap is thereby raised towards the water jet and encounters the inner side of the first flap in such a way that both flaps shut off the passage rearwards and divert the water jet obliquely downwards/forwards. The two flap bearing points on the steering means together with the link arm bearing points on the two flaps provide an equilibrium of forces between the actuator pressure on the first flap and water jet pressure on both flaps, under the condition that a reduction of the pressure on the actuator results in the first flap being swung upwards by the water pressure.
Patent JP-3234231-B2 (JP)
IPC: C01F17/235
Filed: 1996-06-24
Granted: 2001-12-04
Abstract: PCT No. PCT/FR96/00983 Sec. 371 Date Apr. 13, 1998 Sec. 102(e) Date Apr. 13, 1998 PCT Filed Jun. 24, 1996 PCT Pub. No. WO97/02212 PCT Pub. Date Jan. 23, 1997The invention relates to a colloidal dispersion, characterized in that it comprises a cerium oxide and at least one additive chosen from  beta -diketones, monocarboxylic acids containing a hydroxyl function in the  alpha - or  beta -position and diols. It also relates to a redispersible composition in the form of a colloidal dispersion based on cerium oxide and the same above mentioned additives. The colloidal dispersion of the invention can be obtained by a process which is characterized in that at least one above mentioned additive is added to a colloidal dispersion of cerium oxide as the starting material. Finally, the invention relates to the use of a dispersion of the above type or of the type obtained by redispersing a redispersible composition, on a substrate as an anticorrosion agent, in a cosmetics composition, in catalysis, in particular for automobile post-combustion, in lubrication or in ceramics.
Patent JP-2779634-B2 (JP)
IPC: A61M3/00
Filed: 1988-05-31
Granted: 1998-07-23
Abstract: Needle and high velocity jet hypodermic injectors employ a tubular liquid chamber (100), a suitable output port i.e., a needle (506), or a jet port (109), and corresponding means (221), for applying pressure to collapse the liquid bellows (100). The needle injector includes a needle sheath (504), which automatically covers the needle after use and inhibits reuse of the needle (506). The jet injector electronically controls and monitors the system parameters of operation to assure successful injection results.
Patent JP-3271972-B2 (JP)
IPC: H01L29/772
Filed: 1990-03-01
Granted: 2002-04-08
Abstract: PROBLEM TO BE SOLVED: To provide a field effect transistor which is improved for high-density integration. SOLUTION: This field effect transistor has a single-crystal structure semiconductor substrate (11) which has a first conductive type and first impurity density; a source region (12) and a drain region (13) of a second conductive type reverse to the first conductive type, one channel (15) which is positioned between the source region (12) and drain region (13), and has the second conductive type; a gate insulating layer (14) which is formed adjacently to at least one channel, a source contact and a drain contact which are in electric contact with the source region and drain region, and at least one gate contact (18) which is formed on the gate insulating layer, has the first conduction type, and is made of a polycrystalline semiconductor material of the first impurity concentration.
Patent JP-H0678788-B2 (JP)
IPC: F16J15/32
Filed: 1991-02-28
Abstract: A sealing arrangement for sealing a gap (11) between two concentric, antagonistically mobile machine parts, the first machine part (3) having a smooth contact surface (5) and the second machine part (4) having a profiled section (6) facing the contact surface (5) of the first machine part (3), accommodates a packing ring (2). The profiled section (6) is bounded by a first flank (8) and a second flank (9). The packing ring has a curved peripheral surface (7) and a radial surface (13), either of which may be completely exposed to the high pressure side. A sealing edge (10) of the packing ring (2) is formed by the line of intersection of a conical surface (14) and the curved peripheral surface (7). The conical surface (14) merges into the radial surface (13). The packing ring of the invention has a defined pressing distribution and, if the curved peripheral surface (7) faces the high-pressure side, the whole surface of the packing ring is pressed non-positively against the second flank (9) by a pressurized medium.
Patent JP-4199306-B2 (JP)
IPC: A61K47/36
Filed: 1995-07-21
Granted: 2008-12-17
Abstract: An aqueous foamable composition is provided having a delayed foaming action on expulsion from a pressurized container. The composition comprises a major amount of water, a water-immiscible liquified gas foaming agent, at least one foam-stabilizing and emulsifying surfactant, and a water-soluble polymer. The composition is particularly useful for rectal or vaginal administration of pharmaceuticals.
Patent JP-H0561745-B2 (JP)
Inventor: RIHITAA AKUSERU
IPC: F28D15/02
Filed: 1990-04-17
Abstract: PCT No. PCT/EP90/00611 Sec. 371 Date Oct. 29, 1991 Sec. 102(e) Date Oct. 29, 1991 PCT Filed Apr. 17, 1990 PCT Pub. No. WO91/02375 PCT Pub. Date Feb. 21, 1991.An electrostatic pump includes two electrodes, which are spaced apart essentially in the pump flow direction and which are adapted to have applied thereto a potential for injecting an ion current flowing between the two electrodes. For further microminiaturization of the pump, the pump includes two semiconductor components, which are arranged one on top of the other in the pump flow direction and which are so structured that the electrodes form an integral constituent part of the semiconductor components.
Patent JP-3485566-B2 (JP)
IPC: F16L5/02
Filed: 1993-08-25
Granted: 2004-01-13
Abstract: PCT No. PCT/GB93/01810 Sec. 371 Date May 14, 1995 Sec. 102(e) Date May 14, 1995 PCT Filed Aug. 25, 1993 PCT Pub. No. WO94/05943 PCT Pub. Date Mar. 17, 1994A flexible hollow sealing member that can be inflated through a hole in a wall thereof to seal to a first article, the member having: a first sealing material at an inwardly-facing surface of the wall, which first sealing material can be deformed to block the hole by pressure within the member when inflated; and a device for maintaining, during deformation of the first sealing material, separation between the article and an outwardly-facing surface of the wall immediately adjacent the hole.
Patent JP-3261129-B2 (JP)
IPC: A61K9/50
Filed: 1991-04-23
Granted: 2002-02-25
Abstract: The novel uses of the phospholipid-coated microcrystal in the delivery of water-soluble biomolecules such as polypeptides and proteins. The proteins are rendered insoluble by complexation and the resulting material forms the solid core of the phospholipid-coated particle. Alternatively, the proteins, bio-molecules or drugs can be entrapped in water-soluble form between the membranous layers of the coated microcrystal. All types of phospholipid microcrystals can incorporate 5 nm to 10 um diameter iron oxide particles to allow for manipulation by magnetic fields. Water-soluble bio-molecules including proteins, peptides, and drugs can be entrapped and retained with long shelf life in liposomes at high concentrations, provided that the phospholipid concentration is greater than 10% (w/v) such that greater than 50% of the system volume is enclosed within phospholipid membranes. Both the phospholipid-coated microcrystal and the phospholipid-coated microdroplet can be used as vaccine adjuvants.
Patent JP-3999263-B2 (JP)
IPC: A61K31/557
Filed: 1994-09-06
Granted: 2007-10-31
Abstract: PCT No. PCT/US94/09648 Sec. 371 Date Mar. 28, 1996 Sec. 102(e) Date Mar. 28, 1996 PCT Filed Sep. 6, 1994 PCT Pub. No. WO95/11683 PCT Pub. Date May 4, 1995A stable and lyophilized formulation of prostaglandin E-1 made by the process comprising a) dissolving PGE-1 in a solution of lactose and tertiary butyl alcohol wherein said tertiary butyl alcohol is present in an amount of from about 15% to about 33% volume/volume and the ratio of said lactose to PGE-1 is from about 40,000 to 1 to about 10,000 to 1 weight/weight whereby a formulation of PGE-1dispersed in lactose is formed; b) adjusting and maintaining the pH of said formulation from about 3.5 to about 6 with an organic acid buffer; c) freezing said formulation to about -50 DEG  C.; and d) drying said formulation to obtain a moisture content of less than 1% by dry weight and a tertiary butyl alcohol content of less than 3% by dry weight. Preferably, step c) includes after freezing said formulation to about -50 DEG  C., warming to about -25 DEG  C. for about 2 hours then refreezing to about 50 DEG  C. Preferably, the prostaglandin is in an amount of about 25 to 100 ppm in lactose and the pH is maintained at about 4 to 5.
Patent JP-3337476-B2 (JP)
IPC: C07C317/24
Filed: 1996-10-09
Granted: 2002-10-21
Abstract: The invention encompasses the novel compound of formula (I) useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of formula (I).
Patent JP-3634375-B2 (JP)
IPC: G01N33/68
Filed: 1995-11-13
Granted: 2005-03-30
Abstract: Diagnosis and monitoring of Alzheimer's disease (AD) is aided by: (a) measuring the amount of at least one soluble Abeta (x->= 41) peptide (I) in a test sample; (b) comparing the result with a predetermined amount of the same peptide; and (c) assessing patient status from the difference.
Patent JP-4194661-B2 (JP)
IPC: A61M16/18
Filed: 1997-12-09
Granted: 2008-12-10
Abstract: A system is provided for draining an anesthetic agent from a reservoir of an anesthetic vaporizer. The system includes an anesthetic agent container having an inlet into which the agent can drain. The vaporizer has a draining station that defines an outlet and that defines a drain passage between the vaporizer reservoir and the outlet. A valve is operable to open and close the drain passage. A connector is provided with a receiving end for connecting to the draining station at the outlet. The connector has a discharge end for connecting to the container inlet. The connector holds the container below the draining station outlet and defines a transfer passage between the receiving end and the discharge end for draining the agent from the draining station into the container. Structural key configurations, uniquely associated with a specific anesthetic, are preferably provided at the connection of the container and connector and at the connection of the draining station and connector.
Patent JP-4651755-B2 (JP)
IPC: C22C38/00
Filed: 1997-07-24
Granted: 2011-03-16
Abstract: A process for the production of oriented-grain electrical steel sheet with high magnetic characteristics, and more precisely a process in which the slab obtained from continuous casting is continuously nitrided by a reaction between aluminium and nitrogen is described. Amount, size and distribution of precipitates are controlled, enabling a high-temperature continuous heat treatment during which the primary-recrystallization and a high-temperature nitriding are realized.
Patent JP-3322678-B2 (JP)
IPC: G04B19/247
Filed: 1998-05-06
Granted: 2002-09-09
Abstract: Description: (a) a toothed ring (1) raised with 31 more or less long and high notches are urged to replace the ring with the original dates; (b) an 8-toothed star (10) topped with a disk (11) are designed to indicate the ten's of the month through an open window (16) on the dial plate (15). (c) a 10-toothed star (7) topped with a disk (8) is designed to indicate the units of the month through an open window (16) on the dial plate (15); (d) a catch spring (5) maintains the stars in position; (e) a bottom plate (5) of the movement diameter is fixed on the watch movement to link together the components mentioned above. Functioning mode: (a) the toothed ring (1) completes a rotation in 31 days; (b) said ring raised notches move each star one index notch at a time; (c) the stars co-operate with the ring each on a different level; (d) when a notch is shorter or less high, it does not carry the star but stays still; (e) such that the ring is programmed for the disks to indicate through the dial plate the days of the month from 1 to 31 and automatically shift from 31 to 1.
Patent ES-2167253-B2 (ES)
Title: Dispositivo de proteccion de la piel para tratamientos laser y luz pulsada.
Inventor: ARCUSA VILLACAMPA FRANCISCO J
IPC: A61N5/067
Filed: 2000-07-13
Granted: 2003-05-01
Abstract: "Dispositivo de protección de la piel para tratamientos láser y luz pulsada". Comprende una estructura de contacto (2) con la piel (3) del paciente sobre la cual incide un haz de luz láser (4) que está provista de medios de refrigeración (6) adaptados para limitar el calentamiento de la piel (3) durante el tratamiento y un único cristal (5) dotado de un canal de agua (7) que lo rodea perimetralmente por el cual circula de manera continua agua fría. El cristal puede ser zafiro, sílice vítrea y similares, con un espesor entre 0,5 y 6 mm. El agua que circula por el canal (7) se encuentra a una temperatura entre 0 y 20º C.
Patent ES-2238169-B2 (ES)
Title: Soil conditioning material obtained from papermaking bleaching sludge consists of fertilizing and cementing agents incorporated in a product protected against anaerobic fermentation
Inventor: FERNANDEZ MARTINEZ FRANCISCO
IPC: C09K17/40
Filed: 2003-12-16
Granted: 2006-06-01
Abstract: The soil conditioning material obtained from papermaking bleaching sludge comprises recycled paper based agent incorporating e.g. fertilizers and cementing substance. - The process alternatively provides a dry substrate for seeding of slopes to stabilize the slope soil.
Patent ES-2293822-B2 (ES)
Title: Disco abrasivo semiflexible perfeccionado.
Inventor: SONZINI ARTURO
IPC: B24D7/06
Filed: 2006-03-31
Granted: 2009-07-03
Abstract: Disco abrasivo semiflexible perfeccionado. 
     Disco abrasivo semiflexible, comprendiendo un
disco de soporte de radio R1 y de  material sintético estampado,
sobre cuya zona anular externa (4), comprendida entre  un radio
R2<R1 y el radio R1 del disco, se aplica, mediante un adhesivo,
una capa (6)  de granulado abrasivo, en la cual, a partir de un
radio R3 tal que R2=R3<R1, el  espesor de esta zona (5) del disco
de soporte aumenta gradualmente hacia la periferia  del disco
abrasivo, desde un espesor Si hasta un espesor S2>S1. El disco de
soporte  puede presentar, en al menos una parte de la zona (4) sobre
la cual se aplica la capa  (6), unas particulares conformaciones
superficiales (7, 8) en relieve de pequeña  altura, consistentes en
leves relieves lineales radiales y/o circulares concéntricos. 
Preferentemente, el espesor (S1) del disco de soporte es uniforme
desde el centro (0)  del disco hasta el radio R3 en correspondencia
del cual se inicia el aumento de  espesor de la zona periférica (5).
El disco de soporte (1-5) está constituido por una 
resina poliamídica y preferiblemente por nylon 6 o nylon 6.6,
incorporándose un  porcentaje del 20% al 50% de fibra de vidrio.
Patent ES-2588072-B2 (ES)
Title: Proceso de extracción de aceite de oliva mejorado mediante la adición a la pasta de hueso de aceituna previamente acondicionado
Inventor: RINCÓN LEÓN FRANCISCO
IPC: C11B1/00
Filed: 2015-03-26
Granted: 2017-04-28
Abstract: Proceso de extracción de aceite de oliva mejorado mediante la adición a la pasta de hueso de aceituna previamente acondicionado.#La adición de hueso de aceituna previamente acondicionado durante la fase de batido en el proceso extracción del aceite de oliva permite obtener un incremento significativo del rendimiento industrial con respecto al proceso tradicional, mejorando de esta forma el resultado económico del proceso por disminución de los costes de producción e incrementando el cuidado por el medio ambiente, ya que al mejorarse el rendimiento de la extracción se generan efluentes con un menor contenido en aceite y por consiguiente con un mayor grado de agotamiento.
Patent IE-S86899-B2 (IE)
Title: A luminaire with adjustable light directional lens
Inventor: PATRICK FITZGIBBON
IPC: F21V14/00
Filed: 2017-03-20
Abstract: The present invention relates to a luminaire with adjustable light directional lens. In particular the invention provides a luminaire comprising a first fix base containing metal clamps; a second fix head having metal tabs; said second fix head comprising a top housing, a control unit circuit board, a bracket housing and a bottom housing secured together with screw type fixings; and a light source circuit board with directional lens encapsulated within a rotation housing which is held in place between the bracket housing and bottom housing by the pressure exerted by the screw type fixings but with the facility to rotate in a clockwise or anti-clockwise direction when pressure is exerted against the bottom side of the rotation housing. The advantage of the invention is that it allows installers a quick and simple process of installing luminaires with directional lens using standard first and second fixing methods without having to account for the orientation of directional light output until the installation process is complete. <Figure 1>
Patent AU-2001278637-B2 (AU)
Title: Peptide selection method
Inventor: MAZZA GRAZIELLA
IPC: C07K/
Filed: 2001-08-17
Granted: 2006-05-25
Abstract: There is provided a tolerogenic human peptide, capable of binding to an MHC class I or II molecule without further antigen processing, for use in the treatment and/or prevention of multiple sclerosis, which peptide is selected from the following myelin basic protein (MBP) peptides: 83-99 and 131- 145.
Patent AU-2001289469-B2 (AU)
Title: Device for embossing and/or satin-finishing a flat material
Inventor: BOEGLI CHARLES
IPC: B31F1/07
Filed: 2001-10-03
Granted: 2006-12-07
Abstract: A device for satinizing and simultaneously embossing flat materials that includes at least two embossing rolls. One roll is connected to a driving system. The rolls are adapted to be driven individually or in common and are adapted to be resiliently applied against each other. Pyramidal or conical teeth of the rolls have flattened tips. The teeth of at least one roll are shaped so as to produce embossed signs in corresponding locations of the passing flat material so that the appearance of the embossed signs changes according to at least one of a viewing angle of the observer, a kind, and the position of the lighting source.
Patent AU-2002239225-B2 (AU)
Title: Methods of obtaining photoactive coatings and/or anatase crystalline phase of titanium oxides and articles made thereby
Inventor: FINLEY JAMES J
IPC: C23C14/58
Filed: 2001-08-31
Granted: 2006-07-20
Abstract: Hydrophilic and/or rutile and anatase titanium oxide are obtained by sputter depositing titanium metal oxide on a film of zirconium oxide in the cubic phase. Another technique is to deposit a titanium metal on a film of zinc oxide in the cubic phase and heating the coating in an oxidizing atmosphere to provide an anatase and/or rutile phase(s) of titanium oxide.
Patent AU-2002317482-B2 (AU)
Title: 5-halo-tryptamine derivatives used as ligands of the 5-HT6 and/or 5-HT7 serotonin receptors
Inventor: TARZIA GIORGIO
IPC: C07D209/16
Filed: 2002-06-17
Granted: 2007-08-16
Abstract: Compounds of Formula (I): (I); wherein: R<SUB>1 </SUB>and R<SUB>2 </SUB>either the same or different, are H or linear or branched C<SUB>1</SUB>-C<SUB>6 </SUB>alkyl; R<SUB>3</SUB>=linear or branched C<SUB>1</SUB>-C<SUB>6 </SUB>alkyl; R<SUB>4</SUB>=halogen, and pharmaceutically acceptable salts thereof are useful as active ingredients in the preparation of medicaments used as ligands of the 5-HT<SUB>6 </SUB>and/or 5-HT<SUB>7 </SUB>serotoninergic receptors.
Patent AU-2002318292-B2 (AU)
Title: Electro-medical device for use with biologics
Inventor: RUX WILLIAM A
IPC: A61N1/32
Filed: 2002-07-12
Granted: 2007-04-19
Abstract: A multi-functional protable electro-medical device (10) provides interferential current stimulation to promote bone growth. Two electrical signals are applied to a target area, each electrical signal being formed by a set of two electrode pads. A beat frequency is created at the location the signals interest with each other. The beat frequency is the difference between the frequencies of the two signals and has an amplitude that is additive and greater than either signal alone. The depth of the interferential signal is increased by increasing the carrier frequency of the signals. The direction of the interferential signal shifts toward the signal having the lower amplitude. The electrical stimulation is used on a combination with biologics to further increase bone growth. The target area is large enough to include multiple vertebral segments.
Patent AU-2002328855-B2 (AU)
Title: Prostaglandin Analogues As EP4 Receptor Agonists
Inventor: WALKER KEITH ADRIAN MURRAY
IPC: A61P19/08
Filed: 2002-07-08
Granted: 2005-11-24
Abstract: This invention relates to compounds which are generally EP<SUB>4 </SUB>receptor agonists and which are represented by Formula I: wherein A is a -CH<SUB>2</SUB>-CH<SUB>2</SUB>-, or -CH-CH-; B is absent, an aryl, or heteroaryl group; R<SUP>1 </SUP>is alkyl, alkenyl, alkynyl, cycloalkylalkyl, heterocyclylalkyl, aryl, arylalkyl or heteroaryl, when B is aryl or heteroaryl and R<SUP>3</SUP>, R<SUP>4</SUP>, R<SUP>5 </SUP>and R<SUP>6 </SUP>are not simultaneously hydrogen, or R<SUP>1 </SUP>is heterocyclylalkyl, aryl, or heteroaryl when B is absent and R<SUP>3</SUP>, R<SUP>4</SUP>, R<SUP>5 </SUP>and R<SUP>6 </SUP>are simultaneously hydrogen; and the other substituents are as defined in the specification; or individual isomers, racemic or non-racemic mixtures of isomers, or pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing such compounds, methods for their use as therapeutic agents, and methods of preparation thereof.
Patent AU-2003240758-B2 (AU)
Title: Chemokines mutants having improved oral bioavailability
Inventor: KOSCO-VILBOIS MARIE
IPC: A61P31/00
Filed: 2003-03-31
Granted: 2008-03-13
Abstract: The oral efficacy of C-C chemokines containing a dibasic site in the 40's conserved cationic sequence, such as RANTES and MIP-1beta, is improved by substituting at least one of the residues in the dibasic site in a non-conservative manner.
Patent AU-2003288189-B2 (AU)
Title: L-rhamnose-inducible expression systems
Inventor: HAUER BERNHARD
IPC: C12N15/70
Filed: 2003-11-27
Granted: 2009-05-28
Abstract: The present invention relates to methods for expressing nucleic acid sequences in prokaryotic host cells, where at least one DNA construct which is capable of episomal replication in a host cell and which comprises a nucleic acid sequence to be expressed under the transcriptional control of an L-rhamnose-inducible promoter, where the promoter is heterologous with regard to the nucleic acid sequence, is introduced into the host cell and the expression of he nucleic acid sequence is induced by addition of L-rhamnose, wherein the prokaryotic host cell is at least deficient with regard to an L-rhamnose isomerase.